POSITION STATEMENTS
227.000 PHARMACEUTICAL ADVERTISING
227.000 PHARMACEUTICAL ADVERTISING
227.996 Attorney Ads on Drug Side Effects
For attorney commercials that may cause patients to discontinue medically necessary medications, MSSNY, by legislation and/or regulation, will seek to require appropriate warnings that patients should not discontinue medications without seeking the advice of their physician. MSSNY will introduce a similar resolution to the AMA. (HOD 2016-211)
227.997 Pharmaceutical Advertising: SUNSET HOD 2020
227.998 Regulation of Media Advertising of Prescription Drugs: SUNSET HOD 2014
227.999 Cost of Drug Disclosure During Direct Advertising:
MSSNY has adopted the position that pharmaceutical companies include in the consumer advertisement of any pharmaceutical the suggested retail price of such pharmaceutical. (HOD 2001-51; Reaffirmed HOD 2003-252; Reaffirmed HOD 2013; Reaffirmed HOD 2023)
Position Statements